119 related articles for article (PubMed ID: 8154033)
1. Reduction of cyclosporine-induced nephrotoxicity by cilastatin following clinical heart transplantation.
Markewitz A; Hammer C; Pfeiffer M; Zahn S; Drechsel J; Reichenspurner H; Reichart B
Transplantation; 1994 Mar; 57(6):865-70. PubMed ID: 8154033
[TBL] [Abstract][Full Text] [Related]
2. Effect of cilastatin on cyclosporine-induced acute nephrotoxicity in kidney transplant recipients.
Carmellini M; Frosini F; Filipponi F; Boggi U; Mosca F
Transplantation; 1997 Jul; 64(1):164-6. PubMed ID: 9233719
[TBL] [Abstract][Full Text] [Related]
3. Effects of fosfomycin and imipenem-cilastatin on the nephrotoxicity of vancomycin and cisplatin in rats.
Nakamura T; Kokuryo T; Hashimoto Y; Inui KI
J Pharm Pharmacol; 1999 Feb; 51(2):227-32. PubMed ID: 10217324
[TBL] [Abstract][Full Text] [Related]
4. Nephroprotective effect of cilastatin in allogeneic bone marrow transplantation. Results from a retrospective analysis.
Gruss E; Tomás JF; Bernis C; Rodriguez F; Traver JA; Fernández-Rañada JM
Bone Marrow Transplant; 1996 Oct; 18(4):761-5. PubMed ID: 8899192
[TBL] [Abstract][Full Text] [Related]
5. The reversal of experimental cyclosporin A nephrotoxicity by thromboxane synthetase inhibition.
Grieve EM; Hawksworth GM; Simpson JG; Whiting PH
Biochem Pharmacol; 1993 Mar; 45(6):1351-4. PubMed ID: 8466554
[TBL] [Abstract][Full Text] [Related]
6. Prevention of experimental cyclosporine nephrotoxicity by dietary supplementation with LSL 90202, a lysine salt of eicosapentaenoic acid. Role of thromboxane and prostacyclin in renal tissue.
Torras J; Valles J; Sanchez J; Sabate I; Seron D; Carrera M; Castelao AM; Herrero I; Puig-Parellada P; Alsina J
Nephron; 1994; 67(1):66-72. PubMed ID: 8052370
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of ciclosporin-induced nephrotoxicity by dietary supplementation of seal oil in Sprague-Dawley rats.
Yang W; Herzberg GR; Kang Z; Wang L; Robb D; Randell E; Smeda J; Xiong J; Kara M; Liu H
J Pharm Pharmacol; 2005 Nov; 57(11):1485-92. PubMed ID: 16259782
[TBL] [Abstract][Full Text] [Related]
8. Effect of Cilastatin on Cisplatin-Induced Nephrotoxicity in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy.
Zaballos M; Power M; Canal-Alonso MI; González-Nicolás MÁ; Vasquez-Jimenez W; Lozano-Lominchar P; Cabrerizo-Torrente P; Palencia-García N; Gago-Quiroga S; Ginel-Feito MD; Jiménez C; Lázaro A; González-Bayón L
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513824
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of a diet rich in a mixture of n - 6/n - 3 essential fatty acids and of their metabolites on cyclosporine - nephrotoxicity.
Tsipas G; Morphake P
J Nutr Biochem; 2003 Nov; 14(11):626-32. PubMed ID: 14629893
[TBL] [Abstract][Full Text] [Related]
10. Cilastatin protection against cyclosporin A-induced nephrotoxicity: clinical evidence.
Tejedor A; Torres AM; Castilla M; Lazaro JA; de Lucas C; Caramelo C
Curr Med Res Opin; 2007 Mar; 23(3):505-13. PubMed ID: 17355732
[TBL] [Abstract][Full Text] [Related]
11. Safety and tolerability of multiple doses of imipenem/cilastatin.
Drusano GL; Standiford HC; Bustamante CI; Rivera G; Forrest A; Leslie J; Tatem B; Delaportas D; Schimpff SC
Clin Pharmacol Ther; 1985 May; 37(5):539-43. PubMed ID: 3886256
[TBL] [Abstract][Full Text] [Related]
12. Exposure to imipenem/cilastatin causes nephrotoxicity and even urolithiasis in Wistar rats.
Tahri A; Lahyani A; Kallel R; Ayadi F; Boudawara T; Sahnoun Z
Toxicology; 2018 Jul; 404-405():59-67. PubMed ID: 29775647
[TBL] [Abstract][Full Text] [Related]
13. Cilastatin as a protective agent against drug-induced nephrotoxicity: a literature review.
Shayan M; Elyasi S
Expert Opin Drug Saf; 2020 Aug; 19(8):999-1010. PubMed ID: 32666842
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of a diet rich in a mixture of n - 6/n - 3 essential fatty acids and of their metabolites on cyclosporine - nephrotoxicity.
Tsipas G; Morphake P
J Nutr Biochem; 2003 Aug; 14(8):480-6. PubMed ID: 12948879
[TBL] [Abstract][Full Text] [Related]
15. Alleviation of experimental cyclosporin A nephrotoxicity by low dose aspirin in the rat.
Adams KE; Brown PA; Heys SD; Whiting PH
Biochem Pharmacol; 1993 Dec; 46(11):2104-8. PubMed ID: 8267661
[TBL] [Abstract][Full Text] [Related]
16. Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats.
Humanes B; Lazaro A; Camano S; Moreno-Gordaliza E; Lazaro JA; Blanco-Codesido M; Lara JM; Ortiz A; Gomez-Gomez MM; Martín-Vasallo P; Tejedor A
Kidney Int; 2012 Sep; 82(6):652-63. PubMed ID: 22718191
[TBL] [Abstract][Full Text] [Related]
17. Imipenem/cilastatin reduces cyclosporin-induced tubular damage in kidney transplant recipients.
Carmellini M; Matteucci E; Boggi U; Cecconi S; Giampietro O; Mosca F
Transplant Proc; 1998 Aug; 30(5):2034-5. PubMed ID: 9723380
[No Abstract] [Full Text] [Related]
18. Effects of fosfomycin and imipenem/cilastatin on nephrotoxicity and renal excretion of vancomycin in rats.
Nakamura T; Hashimoto Y; Kokuryo T; Inui KI
Pharm Res; 1998 May; 15(5):734-8. PubMed ID: 9619782
[TBL] [Abstract][Full Text] [Related]
19. Nephrotoxicity of vancomycin and drug interaction study with cilastatin in rabbits.
Toyoguchi T; Takahashi S; Hosoya J; Nakagawa Y; Watanabe H
Antimicrob Agents Chemother; 1997 Sep; 41(9):1985-90. PubMed ID: 9303398
[TBL] [Abstract][Full Text] [Related]
20. Cilastatin protects against imipenem-induced nephrotoxicity
Huo X; Meng Q; Wang C; Zhu Y; Liu Z; Ma X; Ma X; Peng J; Sun H; Liu K
Acta Pharm Sin B; 2019 Sep; 9(5):986-996. PubMed ID: 31649848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
